258 results on '"Mostafid, H"'
Search Results
2. The diagnostic accuracy of cystoscopy for detecting bladder cancer in adults presenting with haematuria: A systematic review from the European Association of Urology Guidelines Office
3. Individual patient data validation of the definitions of BCG failure in patients with non-muscle invasive urothelial carcinoma of the bladder: An international multi-centre retrospective study
4. Towards defining follow-up strategies for patients with primary (first diagnosis) EAU2021 intermediate-risk non-muscle invasive bladder cancer
5. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
6. Can experience of blue light cystoscopy improve a surgeon’s white light resection? Data from the PHOTO trial
7. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer
8. RE-TUR + BCG vs. upfront BCG in high-risk non-muscle invasive bladder cancer: A feasibility phase of a randomized controlled study
9. Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)
10. Youtube clips to select low-grade low-stage recurrent Non-Muscle-Invasive Bladder Cancers (NMIBC) for office fulguration, a multinational multi institutional study
11. Best Practices to Optimise Quality and Outcomes of Transurethral Resection of Bladder Tumours
12. What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?
13. Mesh erosion following laparoscopic incisional hernia repair
14. Quality Improvement in Multidisciplinary Cancer Teams: An Investigation of Teamwork and Clinical Decision-Making and Cross-Validation of Assessments
15. Identify : the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer : a multicentre cohort study
16. Corrigendum to ‘EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees’ [European Urology 77 (2020) 223–250](S0302283819307638)(10.1016/j.eururo.2019.09.035)
17. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees
18. The management of hydronephrosis in patients undergoing TURBT
19. Consensus Definition and Prediction of Complexity in Transurethral Resection or Bladder Endoscopic Dissection of Bladder Tumours
20. Transurethral Resection of Bladder Tumour: The Neglected Procedure in the Technology Race in Bladder Cancer
21. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees
22. Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance
23. 182 - Development and external validation of the haematuria cancer risk score to identify patient at risk of harbouring cancer
24. Un patient sur quatre ressent un inconfort significatif lors des cystoscopies de surveillance (TVNIM) dans une étude observationnelle européenne
25. Localised amyloidosis of the bladder: A rare mimic of urinary tract malignancy (case report and literature review)
26. The use of NMP22 as a point of care test for urothelial cancer in a one stop haematuria clinic: 103
27. Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer
28. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees
29. Measles, mumps and rubella – the urologistʼs perspective
30. Do patients with frank haematuria referred under the two-week rule have a higher incidence of bladder cancer?
31. EAU–ESMO consensus statements on the management of advanced and variant bladder cancer - an international collaborative multi-stakeholder effort : under the auspices of the EAU and ESMO Guidelines Committees
32. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
33. Development and validation of a haematuria cancer risk score to identify patients at risk of harbouring cancer
34. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†
35. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort:under the auspices of the EAU and ESMO Guidelines Committees†
36. Emergency dorsal slit for balanitis with retention
37. A NOVEL DEVICE FOR RECONSTITUTING AND DELIVERING INTRAVESICAL CHEMOTHERAPY
38. The self-expanding metallic ureteric stent in the long-term management of benign ureteric strictures: Reply
39. The self-expanding metallic ureteric stent in the long-term management of benign ureteric strictures
40. The responsiveness of the ICSmale questionnaire to outcome: evidence from the ICS-'BPH' study
41. Development and external validation of the haematuria cancer risk score to identify patient at risk of harbouring cancer
42. 12 month results of CALIBER: A phase II randomised feasibility trial of chemoablation with MMC versus surgical management in low risk (LR) non-muscle invasive bladder cancer (NMIBC)
43. Impact of computerized tomography for upper tract imaging and potential role of renal ultrasound in patients presenting with asymptomatic microscopic hematuria
44. The 2-year symptomatic and urodynamic results of a prospective randomized trial of interstitial radiofrequency therapy and TURP
45. Leydig cell tumour of the testis: a rare cause of male infertility
46. The testicular 'tumour' of adrenogenital syndrome: an unusual cause of male infertility
47. Prostatic thermotherapy using Thermex II; 142 cases followed to 3 years: 125
48. Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)
49. Comparison of EndoWrist robotic stapler with laparoscopic stapler in robotic assisted radical cystectomy
50. Early discharge does not increase readmission rate of patients undergoing robotic assisted radical cystectomy with enhanced recovery protocol
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.